Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

SHA:688189 Revenue

Hunan Nucien Pharmaceutical had revenue of 26.05M CNY in the quarter ending March 31, 2026, a decrease of -35.88%. This brings the company's revenue in the last twelve months to 127.35M, down -18.35% year-over-year. In the year 2025, Hunan Nucien Pharmaceutical had annual revenue of 141.93M, down -43.62%.

• Revenue (ttm): 127.35M
• Revenue Growth: -18.35%
• P/S Ratio: 13.35
• Revenue / Employee: 421.69K
• Employees: 302
• Market Cap: 1.70B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.93M	-109.79M	-43.62%
Dec 31, 2024	251.72M	-468.34M	-65.04%
Dec 31, 2023	720.06M	21.24M	3.04%
Dec 31, 2022	698.83M	-44.83M	-6.03%
Dec 31, 2021	743.66M	-285.48M	-27.74%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error